Valuation: Terumo Corporation

Market Cap 3,286B 20.24B 17.7B 16.33B 15.11B 28.67B 1,932B 29.15B 196B 76.64B 949B 75.97B 74.33B P/E 2027 *
19.7x
P/E 2028 * 17.7x
Enterprise Value 3,361B 20.7B 18.11B 16.7B 15.45B 29.33B 1,976B 29.82B 200B 78.41B 970B 77.72B 76.04B EV / Sales 2027 *
2.72x
EV / Sales 2028 * 2.51x
Free-Float
97.07%
Yield 2027 *
1.6%
Yield 2028 * 1.79%
1 day-1.73%
1 week-3.06%
Current month-2.01%
1 month-5.18%
3 months+2.34%
6 months-3.57%
Current year-3.57%
1 week 2,187
Extreme 2187
2,350
1 month 2,146.5
Extreme 2146.5
2,364.5
Current year 1,900
Extreme 1900
2,463
1 year 1,900
Extreme 1900
2,818
3 years 1,856
Extreme 1856
3,182
5 years 1,708
Extreme 1708
3,182
10 years 955
Extreme 955
3,182
Manager TitleAgeSince
Chief Executive Officer 62 01/04/2024
Director of Finance/CFO - -
Chief Tech/Sci/R&D Officer - -
Director TitleAgeSince
Chairman 68 01/04/2022
Director/Board Member 63 21/06/2019
Director/Board Member 75 25/06/2020
Change 5-day change 1-year change 3-year change Capi.($)
-1.73%-3.06%-10.60%+1.91% 20.24B
-0.82%-1.05%-29.14%-11.24% 164B
+0.46%-0.96%-7.43%-4.07% 105B
-2.30%+2.01%+0.77%+58.47% 58.85B
+0.79%-3.68%+40.47%+55.85% 51.05B
+0.19%-4.57%-14.05%-41.29% 41.57B
+1.36%-5.42% - - 34.54B
-1.40%+2.48%-13.96%-42.37% 28.18B
+1.13%-2.21%+58.13%-3.75% 25.27B
+3.11%-1.01%-6.61%-0.85% 21.05B
Average +0.09%-0.89%+1.95%+1.41% 55.06B
Weighted average by Cap. -0.06%-0.73%-6.44%+2.00%

Financials

2027 *2028 *
Net sales 1,236B 7.62B 6.66B 6.14B 5.68B 10.79B 727B 10.97B 73.57B 28.84B 357B 28.59B 27.97B 1,315B 8.1B 7.09B 6.53B 6.05B 11.48B 773B 11.67B 78.25B 30.67B 380B 30.41B 29.75B
Net income 166B 1.02B 892M 822M 761M 1.44B 97.31B 1.47B 9.85B 3.86B 47.78B 3.83B 3.74B 185B 1.14B 998M 920M 851M 1.62B 109B 1.64B 11.02B 4.32B 53.47B 4.28B 4.19B
Net Debt 75.69B 466M 408M 376M 348M 660M 44.5B 671M 4.5B 1.77B 21.85B 1.75B 1.71B 14.29B 88.01M 76.99M 71M 65.69M 125M 8.4B 127M 850M 333M 4.13B 330M 323M
Logo Terumo Corporation
Terumo Corp is a Japan-based company mainly engaged in the manufacture and sale of medical devices and pharmaceuticals. The Company operates in three segments. The Cardiovascular Company segment provides guidewires for angiography, catheters for angiography, introducer sheaths, coils, stents and bag embolization devices for treatment of cerebral aneurysms, artificial lungs and artificial heart-lung machines. The Medical Care Solutions Company segment provides hospital care solutions, life care solutions, and pharmaceutical solutions. The Blood and Cell Technology Company segment provides blood bags, component blood collection systems, automated blood product systems, pathogen reduction systems, and centrifugal blood component separators.
Employees
30,591
Date Price Change Volume
10/07/26 ¥2,189.00 -1.73% 4,601,900
09/07/26 ¥2,227.50 -2.15% 3,400,200
08/07/26 ¥2,276.50 -2.04% 5,188,900
07/07/26 ¥2,324.00 +1.33% 4,707,100
06/07/26 ¥2,293.50 +1.57% 2,726,200
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
14
Last Close Price
2,227.50JPY
Average target price
2,961.54JPY
Spread / Average Target
+32.95%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. 4543 Stock